Immunocore Holdings Plc (IMCR)
30.98
-1.14
(-3.55%)
USD |
NASDAQ |
Oct 23, 16:00
31.07
+0.09
(+0.29%)
After-Hours: 20:00
Immunocore Holdings Price to Book Value : 3.820 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.820 |
| October 22, 2026 | 3.961 |
| October 21, 2026 | 3.957 |
| October 20, 2026 | 4.020 |
| October 19, 2026 | 3.680 |
| October 16, 2026 | 3.626 |
| October 15, 2026 | 3.636 |
| October 14, 2026 | 3.495 |
| October 13, 2026 | 3.431 |
| October 12, 2026 | 3.581 |
| October 09, 2026 | 3.624 |
| October 08, 2026 | 3.587 |
| October 07, 2026 | 3.627 |
| October 06, 2026 | 3.644 |
| October 05, 2026 | 3.649 |
| October 02, 2026 | 3.664 |
| October 01, 2026 | 3.766 |
| September 30, 2026 | 3.735 |
| September 29, 2026 | 3.804 |
| September 28, 2026 | 3.779 |
| September 25, 2026 | 3.788 |
| September 24, 2026 | 3.859 |
| September 23, 2026 | 3.890 |
| September 22, 2026 | 3.998 |
| September 21, 2026 | 3.968 |
| Date | Value |
|---|---|
| September 18, 2026 | 3.946 |
| September 17, 2026 | 3.983 |
| September 16, 2026 | 3.896 |
| September 15, 2026 | 3.918 |
| September 14, 2026 | 4.003 |
| September 11, 2026 | 4.020 |
| September 10, 2026 | 4.141 |
| September 09, 2026 | 4.251 |
| September 08, 2026 | 4.361 |
| September 04, 2026 | 4.456 |
| September 03, 2026 | 4.633 |
| September 02, 2026 | 4.608 |
| September 01, 2026 | 4.546 |
| August 31, 2026 | 4.479 |
| August 28, 2026 | 4.516 |
| August 27, 2026 | 4.532 |
| August 26, 2026 | 4.578 |
| August 25, 2026 | 4.612 |
| August 24, 2026 | 4.515 |
| August 21, 2026 | 4.548 |
| August 20, 2026 | 4.474 |
| August 19, 2026 | 4.546 |
| August 18, 2026 | 4.442 |
| August 17, 2026 | 4.322 |
| August 14, 2026 | 4.219 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Silence Therapeutics Plc | 23.47 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 26.28 |
| Mereo BioPharma Group Plc | 1.569 |
| Compass Pathways Plc | 17.95 |
Price to Book Value Related Metrics
| PS Ratio | 3.688 |
| Price | 30.98 |
| Earnings Yield | -1.19% |
| Market Cap | 1.595B |